CALA Forecast. What You Should Know.
CALA Historical Ratings and Targets
About Calithera Biosciences
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology. It is developing CB-280, an oral arginas... CALA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.